Collectively, these results indicate that FASN is highly expressed in colorectal CSCs and is crucial for maintaining CSC characteristics, promoting spheroid formation, in vivo tumor growth, and preserving the CD133+CD44+ CSC population, thus contributing to CRC progression. The gene discussed is FASN; the disease is colorectal carcinoma.